High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects. [electronic resource]
Producer: 20051229Description: 1249-59 p. digitalISSN:- 0022-1899
- AIDS Vaccines -- administration & dosage
- Double-Blind Method
- Female
- HIV Antibodies -- blood
- HIV Seronegativity -- immunology
- HIV-1 -- immunology
- Humans
- Interferon-gamma -- metabolism
- Male
- Recombinant Proteins -- immunology
- T-Lymphocytes, Cytotoxic -- immunology
- Treatment Outcome
- Vaccination
- Vaccines, Synthetic -- administration & dosage
- Viral Proteins -- genetics
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.